Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Santacruzamate A

Inh 1477949-42-0 N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
N° du produit ABIN7233286

Aperçu rapide pour Santacruzamate A (ABIN7233286)

Application

Inhibition (Inh)

Chemical Name

N-[4-Oxo-4-[(2-phenylethyl)amino]butyl]-carbamic acid, ethyl ester
  • Fonction

    Ultrapotent HDAC2 inhibitor

    Attributs du produit

    A highly potent and selective inhibitor of HDAC2 isolated from the Panamanian marine cyanobacterium cf. Symploca (IC50=0.119 and 434 nM for HDAC2 and HDAC6 respectively). Induces apoptosis and cancer cell death only in combination with other HDAC1 inhibitors. Potential therapeutic agent for breast cancer. Attenuates Aβ fragment (Aβ25-35)-induced toxicity in PC12 cells by enhancing ER stress tolerance. Ameliorates Alzheimer's disease-like pathology in mouse models.

    Pureté

    >98 %

    Formula

    C15H22N2O3

    Solubility

    Soluble in DMSO (up to 25 mg/ml) or in Ethanol (up to 20 mg/ml)
  • Restrictions

    For Research Use only
  • Format

    Powder

    Précaution d'utilisation

    GHS – Classification
    Not a hazardous substance

    Stock

    -20 °C
  • Sujet

    Epigenetics,Posttranslational modification,Protein deacetylase,Neuroscience,Cell death,Cellular stress,Cancer,Neurodegeneration,Apoptosis inducer,Chromatin

    Poids moléculaire

    278.35

    Numéro CAS

    1477949-42-0
Vous êtes ici:
Chat with us!